Lactate dehydrogenase level as a COVID-19 severity marker - 13/07/21
Doi : 10.1016/j.ajem.2020.11.025
Lukasz Szarpak a, b, c, ⁎ 
, Kurt Ruetzler d, Kamil Safiejko a, Michal Hampel e, Michal Pruc c, Luiza Kanczuga - Koda a, Krzysztof Jerzy Filipiak f, Milosz Jaroslaw Jaguszewski g
, Kurt Ruetzler d, Kamil Safiejko a, Michal Hampel e, Michal Pruc c, Luiza Kanczuga - Koda a, Krzysztof Jerzy Filipiak f, Milosz Jaroslaw Jaguszewski g a Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland
b Maria Sklodowska-Curie Medical Academy in Warsaw, Warsaw, Poland
c Polish Society of Disaster Medicine, Warsaw, Poland
d Departments of General Anesthesiology and Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio, USA
e Department of Gastroenterological and Transplant Surgery, Central Clinical Hospital of the Ministry of the Interior and Administration in Warsaw, Warsaw, Poland
f 1st Chair and Department of Cardiology, Medical University of Warsaw, Poland, Warsaw
g 1st Department of Cardiology, Medical University of Gdansk, Gdansk, Poland
⁎Corresponding author at: Maria Sklodowska-Curie Medical Academy in Warsaw, 12 Solidarnosci Av., 03–411 Warsaw, Poland.Maria Sklodowska-Curie Medical Academy in Warsaw12 Solidarnosci Av.Warsaw03–411Poland
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
© 2020
Elsevier Inc. Tous droits réservés.
Vol 45
P. 638-639 - juillet 2021 Retour au numéro
Article précédent
- Prognostic performance of CHA?DS?-VASc scores for predicting mortality among COVID-19 patients: A single pandemic center experience
- Vedat Çiçek, Tufan Ç?nar, Mert ?lker Hay?roglu, ?ahhan K?l?ç, Süha Asal, Samet Yavuz, Murat Selçuk, Ahmet Lütfullah Orhan
- Chronic alcohol use does not protect against COVID-19 infection
- Jacob A. Lebin, Anita Mudan, Alan H.B. Wu
Bienvenue sur EM-consulte, la référence des professionnels de santé.